Three markets, one molecule
Why the same peptide costs several times more from a clinic
A compound sold through a research supplier, a compounding pharmacy and a clinic is in three markets with different legal standing and different obligations. It is not one product at three prices, which is why this site never blends them into a single figure — and why the gap between them, not the price itself, is the number worth publishing.
What each channel actually is
- Research supplier
- Sells material labelled for laboratory research use, not for human use. No prescriber is involved, no pharmacist dispenses it, and no regulator has assessed that particular vial for identity, purity or sterility. What you are quoted is a price per milligram of powder.
- Compounding pharmacy
- A licensed pharmacy preparing a medication against a prescription for an identified patient. A pharmacist is accountable for what is dispensed, and the preparation happens under standards that specify environment, process and, for some categories, testing.
- Clinic or telehealth provider
- A clinical service. The price bundles a consultation, a prescriber, a dispensing route and usually ongoing follow-up. Some price the medication separately from a membership; some do not separate them at all.
What the difference pays for — and what it does not
The honest framing is that a multiple is not a markup on an identical thing. Moving up a channel buys accountability: a named professional who can be asked a question, held to a standard, and who carries responsibility for what is dispensed. Whether that is worth the multiple is a judgement about how much you value that accountability, and this site does not make it for you.
What the difference does not reliably buy is a guarantee about the molecule in any specific vial. A higher price is not evidence of purity, a lower price is not evidence of adulteration, and PepRack does not verify what any seller in any channel ships. Anyone who tells you a price tier answers that question is selling you something.
A per-milligram comparison hides one thing. Clinic and pharmacy channels usually price per month, flat across a dose range, while research suppliers price per milligram. The same monthly fee therefore produces a very different per-mg figure at a low dose than at a high one — and at the top of a titration the two channels can converge or cross entirely. A multiple computed at one dose does not transfer to another.
What we measure, and how
The multiple is expressed band against band, never as a single number: the cheapest research listing against the dearest clinic listing, and the reverse. That is the widest defensible span, and it is never narrowed to flatter it. A point multiple would need a median on both sides, and clinic panels are naturally small — gating on a median would have deleted the metric rather than made it more accurate.
No compound currently has both a research and a clinic band, so no multiple can be computed. This section fills in when a survey round covers both channels for the same compound — it is a gap in collection, not a finding.
What this page is not
It is not advice about which channel to use. It does not tell you that a cheaper channel is a reasonable substitute for a more expensive one, and the legal position of each differs by country and is not addressed here at all. PepRack links to no compound seller in any channel and earns nothing on a compound, which is the only reason it can describe this comparison without a stake in the answer.